QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Identified potential pathogenic variants of BARD1 in 1449 Chinese high-risk breast cancer patients. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Wang, Rong;  Ye, Weiwu;  Chen, Zhanhong;  Shao, Xiying;  Cao, Wenming 收藏  |  浏览/下载：4/0  |  提交时间：2022/12/23 Apatinib combined with chemotherapy versus single chemotherapy in HER-2 negative advanced breast cancer: A randomized, controlled, open-label phase II study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Chen, Zhanhong;  Wang, Xiaojia;  Huang, Jian;  Zheng, Yabing;  Shao, Xiying 收藏  |  浏览/下载：14/0  |  提交时间：2022/12/23 Development of a new HRD algorithm which was highly associated with anthracyclinecontaining neoadjuvant chemotherapy. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Cao, Wen-Ming;  Pan, Jiani;  Wang, Xiaojia;  Lou, Feng;  Li, Mingwei 收藏  |  浏览/下载：8/0  |  提交时间：2022/12/23 BRCANet: A deep hybrid network in predicting BRCA1/2 gene mutation of breast cancer with dynamic contrast-enhanced breast MRI. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Cao, Wen-Ming;  Wang, Xiaojia;  Liu, Jian;  Wang, Lili;  Zhang, Xiaodong 收藏  |  浏览/下载：12/0  |  提交时间：2022/12/23 Efficacy of everolimus-containing chemotherapy in HER2 negative metastatic breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Wang, Rong;  Wang, Xiaojia;  Chen, Zhan-Hong;  Niu, Jin;  Huang, Yuan 收藏  |  浏览/下载：11/0  |  提交时间：2022/01/10 Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9 作者:  Shao, Xiying;  Zheng, Yabing;  Cao, Wenming;  Shen, Xiabo;  Li, Guangliang 收藏  |  浏览/下载：49/0  |  提交时间：2021/06/15 Ki67  progesterone receptor  palbociclib   Primary analysis of OVERSTEP: A multicenter, randomized clinical trial of capecitabine or endocrine therapy as a maintenance therapy after the 1st-line chemotherapy in hormone receptor positive and HER2-negative advanced/metastatic breast cancer 期刊论文 CANCER RESEARCH, 2021, 卷号: 81 作者:  Huang, Jian;  Shao, Xiying;  Cai, Li;  Shi, Yanxia;  Chen, Zhanhong 收藏  |  浏览/下载：28/0  |  提交时间：2021/04/26